Skip to Main Content

Paper Details

Risk of diabetes mellitus among users of immune checkpoint inhibitors: A population-based cohort study.
Cancer Med
3
2023
Author NameAffiliation
Edward Christopher DeeMemorial Sloan Kettering Cancer Center
  • 1 - 1

Datasets

Release 1.2